Publications by authors named "Elyse A Beebe"

Claim this Profile
D
Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach.
Ryan M Kramer, Michelle C Archer, Mark T Orr, Natasha Dubois Cauwelaert, Elyse A Beebe

Int J Nanomedicine· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Antigen-Specific Cellular Immunogenicity Using Intracellular Cytokine Staining, ELISpot, and Culture Supernatants.
Elyse A Beebe, Mark T Orr

Methods Mol Biol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach.
Christopher B Fox, Mark T Orr, Neal Van Hoeven, Sarah C Parker, Traci J T Mikasa, Elyse A Beebe

J Control Release· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.
Susan L Baldwin, Valerie A Reese, Po-Wei D Huang, Elyse A Beebe, Brendan K Podell

Clin Vaccine Immunol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
Mark T Orr, Elyse A Beebe, Thomas E Hudson, David Argilla, Po-Wei D Huang

Vaccine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic Mechanism.
Rhea N Coler, Thomas Hudson, Sean Hughes, Po-Wei D Huang, Elyse A Beebe

J Immunol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.
Mark T Orr, Hillarie Plessner Windish, Elyse A Beebe, David Argilla, Po-Wei D Huang

J Infect Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93.
Mark T Orr, Elyse A Beebe, Thomas E Hudson, James J Moon, Christopher B Fox

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.
Mark T Orr, Gregory C Ireton, Elyse A Beebe, Po-Wei D Huang, Valerie A Reese

J Immunol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization.
Mark T Orr, Ryan M Kramer, Lucien Barnes, Quinton M Dowling, Anthony L Desbien, Elyse A Beebe

J Control Release· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis